Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Bowel Diseases, Inflammatory

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Bowel Diseases, Inflammatory in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oshima, T1
Jordan, P1
Grisham, MB2
Alexander, JS1
Jennings, M1
Sasaki, M1
Manas, K1
Krieglstein, CF1
Cerwinka, WH1
Laroux, FS1
Salter, JW1
Russell, JM1
Schuermann, G1
Ross, CR1
Granger, DN1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Bowel Diseases, Inflammatory

ArticleYear
TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide.
    BMC gastroenterology, 2001, Volume: 1

    Topics: Amidines; Animals; Benzylamines; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Adhesion Molecules;

2001
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.
    The Journal of experimental medicine, 2001, Nov-05, Volume: 194, Issue:9

    Topics: Amidines; Animals; Benzylamines; Colitis, Ulcerative; Colon; Dextran Sulfate; Digestive System; Dige

2001